Shruti Tiwari
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration(2015)284 cited
- → Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor(2016)73 cited
- → Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer(2016)25 cited
- → Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study(2024)23 cited
- → Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?(2021)21 cited
- → Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer(2021)18 cited
- → Abstract PD9-02: Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherapy and/or chemotherapy (chemo): The OXEL study(2022)5 cited
- → Efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab [TCH-P] in non-metastatic HER2+ breast cancer: The Cleveland Clinic experience.(2015)5 cited
- → Renewable Energy based Multimode Electric Vehicle Charging Station: A Review(2022)5 cited